Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
about
Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesMicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocalityMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsRecent advances in hepatocellular carcinoma therapy.Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaquesProteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells.Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignanciesGrowth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes.Regorafenib: an evidence-based review of its potential in patients with advanced liver cancerHepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease.Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditionsTherapeutics Based on microRNA: A New Approach for Liver CancerDefinition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma.MRC2 expression correlates with TGFβ1 and survival in hepatocellular carcinoma.Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma.Common critical pathways in embryogenesis and cancer.c-Myc and transforming growth factor α enhance the development of hepatic lesions due to mutant β-catenin in transgenic miceAssociation of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.Heterogeneity of The CD90(+) Population in Different Stages of Hepatocarcinogenesis.Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.Epigenetics: principles and practice.Chemopreventive strategies in hepatocellular carcinomaRole of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma.Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat StressHepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytesHepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.Dalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating β-catenin degradation in hepatocellular carcinoma cells.Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma CellsMolecular targeted therapies in hepatocellular carcinoma
P2860
Q24320028-8A4E52A5-0C45-4A1C-B268-650E324250E6Q26745338-8D21AA07-0BD2-4713-B312-215C4A5576F4Q28115464-AEAFBB2A-29FF-4EC2-A53F-2A406B3EE2A9Q28383646-EFD7909F-599F-4AAC-A4E8-4869C8ECB741Q30236010-9586E41C-7853-4EE5-A889-E1E436F97DB1Q30502702-0368A1A6-26D7-4BEF-AF68-433F9463FE03Q33298434-08F21F71-4763-462B-A21D-23691C1D3616Q33382038-E85287A4-4466-4DE3-B51A-ABED1CFFAF6FQ33761497-532D2714-22A0-4BE0-B78D-5C8553B3008AQ33826718-B1F4C078-5AB7-4550-AA9E-8AEABD3FEFDFQ33907989-6B137459-58EE-463E-BC29-87F38AD9F1B3Q33916208-15BDBC3A-9055-4F20-BD23-36CBEF13B818Q33944599-96919B61-AD41-4694-9939-BDA35BB60FCFQ34098540-437FEF00-BD2D-4143-83C6-79717E968AB1Q34135528-E8F14DDB-49F2-4245-BED7-A111D573F289Q34148292-6C3D5271-3FDF-436B-A0E1-7A449A11F8E9Q34152847-64D926EE-2C0B-42E4-92F4-CB57E8FB3698Q34268395-DE1CE35F-9A78-4616-BB5D-948066D4C160Q34359058-00A81F21-E7AD-40B7-AC09-BE7FDC65EF3BQ34393261-5909F45B-D8D3-44D4-AFE9-5973FE6BAC85Q34535747-CFF248FA-9B3B-479F-92DA-CBC36E36CB80Q34539365-7C3C3465-992B-4851-B30E-DCE02725649FQ34742406-B182AF0C-E6DA-468E-BCB7-68EEDF78C516Q34765478-A2EC74B4-2B48-4C37-9D8B-625A0FEFA4F7Q34831337-C8AC70F1-0DBA-4D32-9A88-65BC4E0B51D2Q34835189-92636E1B-F577-4447-8F88-C056A477018DQ34845447-44056D18-9729-4DFF-942F-C6165ABC3B44Q35077803-B4EDE638-8EFE-4CF4-A5AC-D1AB9F688644Q35098483-BAE1E435-97BE-4255-A36C-346C20755E1AQ35101365-FD58B326-2F74-4A9B-82C0-BFFC6BBB3EA3Q35282099-FA1DF461-6057-4C4D-80FC-5D3E7D1F05B5Q35991812-81633E7B-0D45-4F45-9B6B-9C30619F5B10Q36126047-591DF7A8-8BF8-4DA4-8389-A64F691AC4A3Q36128222-C3925A37-64BA-412E-ACDA-4A68E99D0FA7Q36166651-776845CC-3564-41FE-98B2-D83F4A4E2090Q36281598-2FA6B005-1725-471B-86C5-CA8543E20B59Q36382856-7EB72CA0-7FDA-469C-8F2F-8FDB08860A28Q36917485-5A4A0ACA-2BF4-4494-9E2A-F4012017DF70Q36956039-8BF8EF56-C05E-4F47-A96F-B0E13B3CFAB4Q37003665-DF4E380D-CFAD-42EF-94B7-68608134269B
P2860
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
@ast
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
@en
type
label
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
@ast
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
@en
prefLabel
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
@ast
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
@en
P356
P1476
Hepatocellular carcinoma: molecular pathways and new therapeutic targets
@en
P304
P356
10.1055/S-2005-871200
P577
2005-01-01T00:00:00Z